TY  - JOUR
AU  - Stević, Ivana
AU  - Petrović, Nemanja
AU  - Janković, Slobodan
PY  - 2023
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/5266
AB  - To satisfy the needs of pediatric and other patients with focal onset seizures who cannot swallow solid dosage forms of zonisamide, an oral liquid form of this drug is necessary in clinical practice. Although there are two oral suspensions of zonisamide with marketing authorization (MA), there are issues of availability and high cost which limit their use and inspire extemporaneous compounding. Extemporaneously compounded oral suspensions of zonisamide are prepared according to different formulas and vary in stability; therefore it is essential to test this characteristic. Bioequivalence of extemporaneously compounded oral suspensions has never been tested, and the efficacy and safety of zonisamide oral suspensions have generally not been demonstrated in clinical trials. As a narrow therapeutic window drug, zonisamide requires precision in dosing, which could be achieved only with dosage forms with established bioavailability, efficacy, and safety. In order to avoid underdosing and toxicity with zonisamide oral suspensions and utilize their full therapeutic potential, it is necessary to perform bioequivalence studies with each variation of extemporaneously compounded oral suspension and also clinical trials with both commercial and extemporaneous oral suspensions of zonisamide.
PB  - Dove Medical Press Ltd
T2  - Patient Preference and Adherence
T1  - Bioequivalence of Different Formulations of Zonisamide Oral Suspensions: A Short Review
VL  - 17
SP  - 2841
EP  - 2845
DO  - 10.2147/PPA.S383038
ER  - 

@article{
author = "Stević, Ivana and Petrović, Nemanja and Janković, Slobodan",
year = "2023",
abstract = "To satisfy the needs of pediatric and other patients with focal onset seizures who cannot swallow solid dosage forms of zonisamide, an oral liquid form of this drug is necessary in clinical practice. Although there are two oral suspensions of zonisamide with marketing authorization (MA), there are issues of availability and high cost which limit their use and inspire extemporaneous compounding. Extemporaneously compounded oral suspensions of zonisamide are prepared according to different formulas and vary in stability; therefore it is essential to test this characteristic. Bioequivalence of extemporaneously compounded oral suspensions has never been tested, and the efficacy and safety of zonisamide oral suspensions have generally not been demonstrated in clinical trials. As a narrow therapeutic window drug, zonisamide requires precision in dosing, which could be achieved only with dosage forms with established bioavailability, efficacy, and safety. In order to avoid underdosing and toxicity with zonisamide oral suspensions and utilize their full therapeutic potential, it is necessary to perform bioequivalence studies with each variation of extemporaneously compounded oral suspension and also clinical trials with both commercial and extemporaneous oral suspensions of zonisamide.",
publisher = "Dove Medical Press Ltd",
journal = "Patient Preference and Adherence",
title = "Bioequivalence of Different Formulations of Zonisamide Oral Suspensions: A Short Review",
volume = "17",
pages = "2841-2845",
doi = "10.2147/PPA.S383038"
}

Stević, I., Petrović, N.,& Janković, S.. (2023). Bioequivalence of Different Formulations of Zonisamide Oral Suspensions: A Short Review. in Patient Preference and Adherence
Dove Medical Press Ltd., 17, 2841-2845.
https://doi.org/10.2147/PPA.S383038

Stević I, Petrović N, Janković S. Bioequivalence of Different Formulations of Zonisamide Oral Suspensions: A Short Review. in Patient Preference and Adherence. 2023;17:2841-2845.
doi:10.2147/PPA.S383038 .

Stević, Ivana, Petrović, Nemanja, Janković, Slobodan, "Bioequivalence of Different Formulations of Zonisamide Oral Suspensions: A Short Review" in Patient Preference and Adherence, 17 (2023):2841-2845,
https://doi.org/10.2147/PPA.S383038 . .

TY  - JOUR
AU  - Antanasković, Ana
AU  - Stević, Ivana
AU  - Gojak, Refet
AU  - Lakić, Dragana
AU  - Janković, Slobodan
PY  - 2023
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/5269
AB  - Alpha-mannosidosis is an inherited rare disorder of mannose-containing oligosaccharides metabolism that is currently treated by enzyme replacement therapy (ERT), bone marrow transplantation (BMT), or supportive therapy (ST). However, the relative cost-effectiveness of these treatment options is yet unknown. Our study aimed to compare the cost-effectiveness of the treatment options for mild to moderate alpha-mannosidosis. The study is based on a modeling approach using a Discrete-Event Simulation model to generate and simulate the course of the disease under the influence of each of the treatment options: ERT, BMT, and ST. The model had a lifetime horizon and was made from the perspective of the Serbian Health Insurance Fund. Currently, available causal therapy of mild to moderate alpha-mannosidosis with velmanase alpha enzyme replacement is not cost-effective compared with supportive therapy (ICER = 941,587,152 RSD) or bone marrow transplantation (ICER = −398,412,755 RSD). Bone marrow transplantation can be cost-effective compared to supportive therapy (ICER = 6,032,689 RSD), but only if the willingness-to-pay threshold is increased to 9 gross domestic products (GDP) per capita per QALY gained. According to the current threshold, velmanase-alfa is not cost-effective compared to BMT or ST. To make alfa-mannosidosis therapy widely accessible to patients, criteria for assessing the cost-effectiveness of orphan drugs must include not only the absolute value of ICER but other aspects like equity weightings of QALYs, risk-sharing, reimbursement of severe forms of a disease only, or availability of dedicated funding.
PB  - Taylor and Francis Ltd.
T2  - Biotechnology and Biotechnological Equipment
T1  - Cost-effectiveness of velmanase alfa vs. bone marrow transplantation or no causal therapy in patients with mild to moderate alpha-mannosidosis
VL  - 37
IS  - 1
DO  - 10.1080/13102818.2023.2271574
ER  - 

@article{
author = "Antanasković, Ana and Stević, Ivana and Gojak, Refet and Lakić, Dragana and Janković, Slobodan",
year = "2023",
abstract = "Alpha-mannosidosis is an inherited rare disorder of mannose-containing oligosaccharides metabolism that is currently treated by enzyme replacement therapy (ERT), bone marrow transplantation (BMT), or supportive therapy (ST). However, the relative cost-effectiveness of these treatment options is yet unknown. Our study aimed to compare the cost-effectiveness of the treatment options for mild to moderate alpha-mannosidosis. The study is based on a modeling approach using a Discrete-Event Simulation model to generate and simulate the course of the disease under the influence of each of the treatment options: ERT, BMT, and ST. The model had a lifetime horizon and was made from the perspective of the Serbian Health Insurance Fund. Currently, available causal therapy of mild to moderate alpha-mannosidosis with velmanase alpha enzyme replacement is not cost-effective compared with supportive therapy (ICER = 941,587,152 RSD) or bone marrow transplantation (ICER = −398,412,755 RSD). Bone marrow transplantation can be cost-effective compared to supportive therapy (ICER = 6,032,689 RSD), but only if the willingness-to-pay threshold is increased to 9 gross domestic products (GDP) per capita per QALY gained. According to the current threshold, velmanase-alfa is not cost-effective compared to BMT or ST. To make alfa-mannosidosis therapy widely accessible to patients, criteria for assessing the cost-effectiveness of orphan drugs must include not only the absolute value of ICER but other aspects like equity weightings of QALYs, risk-sharing, reimbursement of severe forms of a disease only, or availability of dedicated funding.",
publisher = "Taylor and Francis Ltd.",
journal = "Biotechnology and Biotechnological Equipment",
title = "Cost-effectiveness of velmanase alfa vs. bone marrow transplantation or no causal therapy in patients with mild to moderate alpha-mannosidosis",
volume = "37",
number = "1",
doi = "10.1080/13102818.2023.2271574"
}

Antanasković, A., Stević, I., Gojak, R., Lakić, D.,& Janković, S.. (2023). Cost-effectiveness of velmanase alfa vs. bone marrow transplantation or no causal therapy in patients with mild to moderate alpha-mannosidosis. in Biotechnology and Biotechnological Equipment
Taylor and Francis Ltd.., 37(1).
https://doi.org/10.1080/13102818.2023.2271574

Antanasković A, Stević I, Gojak R, Lakić D, Janković S. Cost-effectiveness of velmanase alfa vs. bone marrow transplantation or no causal therapy in patients with mild to moderate alpha-mannosidosis. in Biotechnology and Biotechnological Equipment. 2023;37(1).
doi:10.1080/13102818.2023.2271574 .

Antanasković, Ana, Stević, Ivana, Gojak, Refet, Lakić, Dragana, Janković, Slobodan, "Cost-effectiveness of velmanase alfa vs. bone marrow transplantation or no causal therapy in patients with mild to moderate alpha-mannosidosis" in Biotechnology and Biotechnological Equipment, 37, no. 1 (2023),
https://doi.org/10.1080/13102818.2023.2271574 . .

TY  - JOUR
AU  - Janković, Slobodan
AU  - Bogavac-Stanojević, Nataša
AU  - Mikulić, Iva
AU  - Izetbegović, Sebija
AU  - Iličković, Ivana
AU  - Krajnović, Dušanka
AU  - Suljic Mehmedika, Enra
AU  - Gojak, Refet
AU  - Mehičević, Admir
AU  - Gazibera, Belma
AU  - Mahmutbegović, Nevena
AU  - Stojadinović, Milorad
AU  - Janković, Nikola
AU  - Miljković, Sanja
AU  - Popović, Slađana
AU  - Blidarević, Bojan
AU  - Mugoša, Snežana
AU  - Đorđević, Zorana
PY  - 2021
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/3994
AB  - Prenos instrumentov za merjenje kakovosti življenja, razvitih v nekaterih, večinoma razvitejših delih sveta, zahteva transkulturno validacijo. Kljub temu tovrstni instrumenti običajno ne zajemajo regionalno specifičnih vidikov kakovosti življenja, povezanih z zdravjem. Namen študije je bil razviti in potrditi zanesljiv vprašalnik v srbskem, hrvaškem, bosansko-hrvaško-srbskem in črnogorskem jeziku, primeren za merjenje kakovosti življenja, povezanega z zdravjem odraslih.
AB  - Translations of instruments for measuring quality of life developed in certain, mostly more
developed, parts of the world usually do not cover regionally specific aspects of health-related quality of life,
even after transcultural validation. The aim of this study was to develop and validate a reliable questionnaire
in Serbian, Croatian, Bosnian, and Montenegrin languages suitable for measuring health-related quality of life
in adults.
PB  - Sciendo
T2  - Zdravstveno varstvo
T1  - Vprašalnik za merjenje kakovosti življenja, povezanega z zdravjem
T1  - A questionnaire for rating health-related quality of life
VL  - 60
IS  - 4
SP  - 260
EP  - 268
DO  - 10.2478/sjph-2021-0035
ER  - 

@article{
author = "Janković, Slobodan and Bogavac-Stanojević, Nataša and Mikulić, Iva and Izetbegović, Sebija and Iličković, Ivana and Krajnović, Dušanka and Suljic Mehmedika, Enra and Gojak, Refet and Mehičević, Admir and Gazibera, Belma and Mahmutbegović, Nevena and Stojadinović, Milorad and Janković, Nikola and Miljković, Sanja and Popović, Slađana and Blidarević, Bojan and Mugoša, Snežana and Đorđević, Zorana",
year = "2021",
abstract = "Prenos instrumentov za merjenje kakovosti življenja, razvitih v nekaterih, večinoma razvitejših delih sveta, zahteva transkulturno validacijo. Kljub temu tovrstni instrumenti običajno ne zajemajo regionalno specifičnih vidikov kakovosti življenja, povezanih z zdravjem. Namen študije je bil razviti in potrditi zanesljiv vprašalnik v srbskem, hrvaškem, bosansko-hrvaško-srbskem in črnogorskem jeziku, primeren za merjenje kakovosti življenja, povezanega z zdravjem odraslih., Translations of instruments for measuring quality of life developed in certain, mostly more
developed, parts of the world usually do not cover regionally specific aspects of health-related quality of life,
even after transcultural validation. The aim of this study was to develop and validate a reliable questionnaire
in Serbian, Croatian, Bosnian, and Montenegrin languages suitable for measuring health-related quality of life
in adults.",
publisher = "Sciendo",
journal = "Zdravstveno varstvo",
title = "Vprašalnik za merjenje kakovosti življenja, povezanega z zdravjem, A questionnaire for rating health-related quality of life",
volume = "60",
number = "4",
pages = "260-268",
doi = "10.2478/sjph-2021-0035"
}

Janković, S., Bogavac-Stanojević, N., Mikulić, I., Izetbegović, S., Iličković, I., Krajnović, D., Suljic Mehmedika, E., Gojak, R., Mehičević, A., Gazibera, B., Mahmutbegović, N., Stojadinović, M., Janković, N., Miljković, S., Popović, S., Blidarević, B., Mugoša, S.,& Đorđević, Z.. (2021). Vprašalnik za merjenje kakovosti življenja, povezanega z zdravjem. in Zdravstveno varstvo
Sciendo., 60(4), 260-268.
https://doi.org/10.2478/sjph-2021-0035

Janković S, Bogavac-Stanojević N, Mikulić I, Izetbegović S, Iličković I, Krajnović D, Suljic Mehmedika E, Gojak R, Mehičević A, Gazibera B, Mahmutbegović N, Stojadinović M, Janković N, Miljković S, Popović S, Blidarević B, Mugoša S, Đorđević Z. Vprašalnik za merjenje kakovosti življenja, povezanega z zdravjem. in Zdravstveno varstvo. 2021;60(4):260-268.
doi:10.2478/sjph-2021-0035 .

Janković, Slobodan, Bogavac-Stanojević, Nataša, Mikulić, Iva, Izetbegović, Sebija, Iličković, Ivana, Krajnović, Dušanka, Suljic Mehmedika, Enra, Gojak, Refet, Mehičević, Admir, Gazibera, Belma, Mahmutbegović, Nevena, Stojadinović, Milorad, Janković, Nikola, Miljković, Sanja, Popović, Slađana, Blidarević, Bojan, Mugoša, Snežana, Đorđević, Zorana, "Vprašalnik za merjenje kakovosti življenja, povezanega z zdravjem" in Zdravstveno varstvo, 60, no. 4 (2021):260-268,
https://doi.org/10.2478/sjph-2021-0035 . .

TY  - JOUR
AU  - Vlaisavljević, Željko
AU  - Janković, Slobodan
AU  - Maksimović, Nataša
AU  - Ćulafić, Milica
AU  - Štulić, Miloš
AU  - Milovanović, Tamara
AU  - Oluić, Branislav
PY  - 2020
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/3559
AB  - Objective. Nurses represent the key persons in the process of organ donation, acting as intermediaries between the patient and the family of a potential donor. The aim of this study was to analyze the factors influencing the attitudes of nurses toward bequeathing and organ and tissue donation. Methods. The research was designed as a cross-sectional study from November 2013 to November 2014 and included a sample of 264 nurses employed in the health system of Serbia. Data were collected using a specific questionnaire of 18 questions referring to the information on sociodemographic characteristics and the knowledge of organ donation. Results. The investigation enrolled 264 participants, of which 78% were women. The majority of study subjects had secondary medical education (64.4%), lived in an urban area (82.6%), were married (56.4%), and were predominantly Orthodox (87.1%) with their work experience between 5 and 10 years (29.9%) and 10 to 20 years (29.5%). The average knowledge score concerning organ donation was 29.03 (SD, 2.33; range, 23-34). There was a statistically significant difference in the scores between 2 groups formed according the length of service (P < .001) and the level of education (P ¼ .019), which showed the strongest influence on nurses’ attitudes toward donation. Conclusion. This investigation showed that nurses did not express strong positive attitude toward this issue. Further education of nurses in the Serbian health care system focusing on transplantation and bequeathing of organs and tissues are warranted. N
PB  - Elsevier USA
T2  - Transplantation Proceedings
T1  - Attitudes of Nurses Toward Organ Donation in Serbia
VL  - 52
IS  - 3
SP  - 673
EP  - 679
DO  - 10.1016/j.transproceed.2020.01.031
ER  - 

@article{
author = "Vlaisavljević, Željko and Janković, Slobodan and Maksimović, Nataša and Ćulafić, Milica and Štulić, Miloš and Milovanović, Tamara and Oluić, Branislav",
year = "2020",
abstract = "Objective. Nurses represent the key persons in the process of organ donation, acting as intermediaries between the patient and the family of a potential donor. The aim of this study was to analyze the factors influencing the attitudes of nurses toward bequeathing and organ and tissue donation. Methods. The research was designed as a cross-sectional study from November 2013 to November 2014 and included a sample of 264 nurses employed in the health system of Serbia. Data were collected using a specific questionnaire of 18 questions referring to the information on sociodemographic characteristics and the knowledge of organ donation. Results. The investigation enrolled 264 participants, of which 78% were women. The majority of study subjects had secondary medical education (64.4%), lived in an urban area (82.6%), were married (56.4%), and were predominantly Orthodox (87.1%) with their work experience between 5 and 10 years (29.9%) and 10 to 20 years (29.5%). The average knowledge score concerning organ donation was 29.03 (SD, 2.33; range, 23-34). There was a statistically significant difference in the scores between 2 groups formed according the length of service (P < .001) and the level of education (P ¼ .019), which showed the strongest influence on nurses’ attitudes toward donation. Conclusion. This investigation showed that nurses did not express strong positive attitude toward this issue. Further education of nurses in the Serbian health care system focusing on transplantation and bequeathing of organs and tissues are warranted. N",
publisher = "Elsevier USA",
journal = "Transplantation Proceedings",
title = "Attitudes of Nurses Toward Organ Donation in Serbia",
volume = "52",
number = "3",
pages = "673-679",
doi = "10.1016/j.transproceed.2020.01.031"
}

Vlaisavljević, Ž., Janković, S., Maksimović, N., Ćulafić, M., Štulić, M., Milovanović, T.,& Oluić, B.. (2020). Attitudes of Nurses Toward Organ Donation in Serbia. in Transplantation Proceedings
Elsevier USA., 52(3), 673-679.
https://doi.org/10.1016/j.transproceed.2020.01.031

Vlaisavljević Ž, Janković S, Maksimović N, Ćulafić M, Štulić M, Milovanović T, Oluić B. Attitudes of Nurses Toward Organ Donation in Serbia. in Transplantation Proceedings. 2020;52(3):673-679.
doi:10.1016/j.transproceed.2020.01.031 .

Vlaisavljević, Željko, Janković, Slobodan, Maksimović, Nataša, Ćulafić, Milica, Štulić, Miloš, Milovanović, Tamara, Oluić, Branislav, "Attitudes of Nurses Toward Organ Donation in Serbia" in Transplantation Proceedings, 52, no. 3 (2020):673-679,
https://doi.org/10.1016/j.transproceed.2020.01.031 . .

TY  - JOUR
AU  - Radovanović, Ana M.
AU  - Cupara, Snežana
AU  - Popović, Suzana L. J.
AU  - Tomović, Marina T.
AU  - Slavkovska, Violeta
AU  - Janković, Slobodan
PY  - 2013
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/1869
AB  - Potentilla reptans L. belongs to the least studied of the plants from Rosaceae family, Potentilla genus. There are no data on cytotoxicity of P. reptans extracts, though traditionaly it was used as anti-inflammatory and antiinfective. The aim of these studies was to investigate potential antitumor activity of aqueous extracts (rhizome and aerial parts) of P. reptans on 4T1 mouse breast cancer cell line._Aqueous extracts of rhizome and aerial parts of P. reptans were tested for cytotoxicity by the MTT colorimetric assay on 4T1 cancer cell line in concentration range 100-800 mu g/mL. Aqueous extracts of P. reptans rhizome and aerial parts show concentration dependent cytotoxic effect in the range of tested concentrations. IC50 value of P. reptans rhizome extract was 280.51 +/- 1.16 mu g/mL. IC50 value of P. reptans aerial parts extract was 310.79 +/- 1.22 mu g/mL. The significant difference in cytotoxicity among tested concentrations was observed. Aqueous extracts of P. mptans rhizome and aerial parts demonstrated weak cytotoxic activity on 4T1 mouse breast cancer cell line, which is in correlation with current cytotoxicity data for aqueous herbal extracts. Rhizome extract of P. reptans has slightly higher antitumor activity than aerial parts extract. The results represent the first report on cytotoxicity for this plant and further research on human cell lines is indicated.
PB  - Polskie Towarzystwo Farmaceutyczne, Warsaw
T2  - Acta Poloniae Pharmaceutica - Drug Research
T1  - Cytotoxic effect of Potentilla reptans L. rhizome and aerial part extracts
VL  - 70
IS  - 5
SP  - 851
EP  - 854
UR  - https://hdl.handle.net/21.15107/rcub_farfar_1869
ER  - 

@article{
author = "Radovanović, Ana M. and Cupara, Snežana and Popović, Suzana L. J. and Tomović, Marina T. and Slavkovska, Violeta and Janković, Slobodan",
year = "2013",
abstract = "Potentilla reptans L. belongs to the least studied of the plants from Rosaceae family, Potentilla genus. There are no data on cytotoxicity of P. reptans extracts, though traditionaly it was used as anti-inflammatory and antiinfective. The aim of these studies was to investigate potential antitumor activity of aqueous extracts (rhizome and aerial parts) of P. reptans on 4T1 mouse breast cancer cell line._Aqueous extracts of rhizome and aerial parts of P. reptans were tested for cytotoxicity by the MTT colorimetric assay on 4T1 cancer cell line in concentration range 100-800 mu g/mL. Aqueous extracts of P. reptans rhizome and aerial parts show concentration dependent cytotoxic effect in the range of tested concentrations. IC50 value of P. reptans rhizome extract was 280.51 +/- 1.16 mu g/mL. IC50 value of P. reptans aerial parts extract was 310.79 +/- 1.22 mu g/mL. The significant difference in cytotoxicity among tested concentrations was observed. Aqueous extracts of P. mptans rhizome and aerial parts demonstrated weak cytotoxic activity on 4T1 mouse breast cancer cell line, which is in correlation with current cytotoxicity data for aqueous herbal extracts. Rhizome extract of P. reptans has slightly higher antitumor activity than aerial parts extract. The results represent the first report on cytotoxicity for this plant and further research on human cell lines is indicated.",
publisher = "Polskie Towarzystwo Farmaceutyczne, Warsaw",
journal = "Acta Poloniae Pharmaceutica - Drug Research",
title = "Cytotoxic effect of Potentilla reptans L. rhizome and aerial part extracts",
volume = "70",
number = "5",
pages = "851-854",
url = "https://hdl.handle.net/21.15107/rcub_farfar_1869"
}

Radovanović, A. M., Cupara, S., Popović, S. L. J., Tomović, M. T., Slavkovska, V.,& Janković, S.. (2013). Cytotoxic effect of Potentilla reptans L. rhizome and aerial part extracts. in Acta Poloniae Pharmaceutica - Drug Research
Polskie Towarzystwo Farmaceutyczne, Warsaw., 70(5), 851-854.
https://hdl.handle.net/21.15107/rcub_farfar_1869

Radovanović AM, Cupara S, Popović SLJ, Tomović MT, Slavkovska V, Janković S. Cytotoxic effect of Potentilla reptans L. rhizome and aerial part extracts. in Acta Poloniae Pharmaceutica - Drug Research. 2013;70(5):851-854.
https://hdl.handle.net/21.15107/rcub_farfar_1869 .

Radovanović, Ana M., Cupara, Snežana, Popović, Suzana L. J., Tomović, Marina T., Slavkovska, Violeta, Janković, Slobodan, "Cytotoxic effect of Potentilla reptans L. rhizome and aerial part extracts" in Acta Poloniae Pharmaceutica - Drug Research, 70, no. 5 (2013):851-854,
https://hdl.handle.net/21.15107/rcub_farfar_1869 .

TY  - CONF
AU  - Stojanović, Branka
AU  - Miljković, Branislava
AU  - Janković, Slobodan
PY  - 2007
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/973
PB  - Springer, Dordrecht
C3  - Pharmacy World & Science
T1  - Identification of medication errors in emergency department of University Hospital Kragujevac
VL  - 29
IS  - 5
SP  - 478
EP  - 478
UR  - https://hdl.handle.net/21.15107/rcub_farfar_973
ER  - 

@conference{
author = "Stojanović, Branka and Miljković, Branislava and Janković, Slobodan",
year = "2007",
publisher = "Springer, Dordrecht",
journal = "Pharmacy World & Science",
title = "Identification of medication errors in emergency department of University Hospital Kragujevac",
volume = "29",
number = "5",
pages = "478-478",
url = "https://hdl.handle.net/21.15107/rcub_farfar_973"
}

Stojanović, B., Miljković, B.,& Janković, S.. (2007). Identification of medication errors in emergency department of University Hospital Kragujevac. in Pharmacy World & Science
Springer, Dordrecht., 29(5), 478-478.
https://hdl.handle.net/21.15107/rcub_farfar_973

Stojanović B, Miljković B, Janković S. Identification of medication errors in emergency department of University Hospital Kragujevac. in Pharmacy World & Science. 2007;29(5):478-478.
https://hdl.handle.net/21.15107/rcub_farfar_973 .

Stojanović, Branka, Miljković, Branislava, Janković, Slobodan, "Identification of medication errors in emergency department of University Hospital Kragujevac" in Pharmacy World & Science, 29, no. 5 (2007):478-478,
https://hdl.handle.net/21.15107/rcub_farfar_973 .

TY  - CONF
AU  - Jovanović, Daliborka
AU  - Stojanović, Branka
AU  - Miljković, Branislava
AU  - Janković, Slobodan
PY  - 2007
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/971
PB  - Springer, Dordrecht
C3  - Pharmacy World & Science
T1  - Evaluation of the introduction of Quality measures in Medicines Management in general hospital in Serbia
VL  - 29
IS  - 5
SP  - 511
EP  - 512
UR  - https://hdl.handle.net/21.15107/rcub_farfar_971
ER  - 

@conference{
author = "Jovanović, Daliborka and Stojanović, Branka and Miljković, Branislava and Janković, Slobodan",
year = "2007",
publisher = "Springer, Dordrecht",
journal = "Pharmacy World & Science",
title = "Evaluation of the introduction of Quality measures in Medicines Management in general hospital in Serbia",
volume = "29",
number = "5",
pages = "511-512",
url = "https://hdl.handle.net/21.15107/rcub_farfar_971"
}

Jovanović, D., Stojanović, B., Miljković, B.,& Janković, S.. (2007). Evaluation of the introduction of Quality measures in Medicines Management in general hospital in Serbia. in Pharmacy World & Science
Springer, Dordrecht., 29(5), 511-512.
https://hdl.handle.net/21.15107/rcub_farfar_971

Jovanović D, Stojanović B, Miljković B, Janković S. Evaluation of the introduction of Quality measures in Medicines Management in general hospital in Serbia. in Pharmacy World & Science. 2007;29(5):511-512.
https://hdl.handle.net/21.15107/rcub_farfar_971 .

Jovanović, Daliborka, Stojanović, Branka, Miljković, Branislava, Janković, Slobodan, "Evaluation of the introduction of Quality measures in Medicines Management in general hospital in Serbia" in Pharmacy World & Science, 29, no. 5 (2007):511-512,
https://hdl.handle.net/21.15107/rcub_farfar_971 .

TY  - CONF
AU  - Stojanović, Branka
AU  - Miljković, Branislava
AU  - Janković, Slobodan
PY  - 2007
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/963
PB  - Springer, Dordrecht
C3  - Pharmacy World & Science
T1  - Implementation of Quality measures in Medicines Management and its influence on antibiotic utilisation in Paediatric Ward in Serbia
VL  - 29
IS  - 5
SP  - 511
EP  - 511
UR  - https://hdl.handle.net/21.15107/rcub_farfar_963
ER  - 

@conference{
author = "Stojanović, Branka and Miljković, Branislava and Janković, Slobodan",
year = "2007",
publisher = "Springer, Dordrecht",
journal = "Pharmacy World & Science",
title = "Implementation of Quality measures in Medicines Management and its influence on antibiotic utilisation in Paediatric Ward in Serbia",
volume = "29",
number = "5",
pages = "511-511",
url = "https://hdl.handle.net/21.15107/rcub_farfar_963"
}

Stojanović, B., Miljković, B.,& Janković, S.. (2007). Implementation of Quality measures in Medicines Management and its influence on antibiotic utilisation in Paediatric Ward in Serbia. in Pharmacy World & Science
Springer, Dordrecht., 29(5), 511-511.
https://hdl.handle.net/21.15107/rcub_farfar_963

Stojanović B, Miljković B, Janković S. Implementation of Quality measures in Medicines Management and its influence on antibiotic utilisation in Paediatric Ward in Serbia. in Pharmacy World & Science. 2007;29(5):511-511.
https://hdl.handle.net/21.15107/rcub_farfar_963 .

Stojanović, Branka, Miljković, Branislava, Janković, Slobodan, "Implementation of Quality measures in Medicines Management and its influence on antibiotic utilisation in Paediatric Ward in Serbia" in Pharmacy World & Science, 29, no. 5 (2007):511-511,
https://hdl.handle.net/21.15107/rcub_farfar_963 .